1. Home
  2. MAIA vs AMPG Comparison

MAIA vs AMPG Comparison

Compare MAIA & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIA
  • AMPG
  • Stock Information
  • Founded
  • MAIA 2018
  • AMPG 2002
  • Country
  • MAIA United States
  • AMPG United States
  • Employees
  • MAIA N/A
  • AMPG N/A
  • Industry
  • MAIA Biotechnology: Pharmaceutical Preparations
  • AMPG Telecommunications Equipment
  • Sector
  • MAIA Health Care
  • AMPG Telecommunications
  • Exchange
  • MAIA Nasdaq
  • AMPG Nasdaq
  • Market Cap
  • MAIA 56.3M
  • AMPG 46.7M
  • IPO Year
  • MAIA 2022
  • AMPG N/A
  • Fundamental
  • Price
  • MAIA $1.58
  • AMPG $3.10
  • Analyst Decision
  • MAIA
  • AMPG Strong Buy
  • Analyst Count
  • MAIA 0
  • AMPG 1
  • Target Price
  • MAIA N/A
  • AMPG $5.00
  • AVG Volume (30 Days)
  • MAIA 398.8K
  • AMPG 774.6K
  • Earning Date
  • MAIA 08-11-2025
  • AMPG 08-14-2025
  • Dividend Yield
  • MAIA N/A
  • AMPG N/A
  • EPS Growth
  • MAIA N/A
  • AMPG N/A
  • EPS
  • MAIA N/A
  • AMPG N/A
  • Revenue
  • MAIA N/A
  • AMPG $19,312,625.00
  • Revenue This Year
  • MAIA N/A
  • AMPG $114.55
  • Revenue Next Year
  • MAIA N/A
  • AMPG $50.00
  • P/E Ratio
  • MAIA N/A
  • AMPG N/A
  • Revenue Growth
  • MAIA N/A
  • AMPG 58.04
  • 52 Week Low
  • MAIA $1.40
  • AMPG $0.64
  • 52 Week High
  • MAIA $3.74
  • AMPG $6.43
  • Technical
  • Relative Strength Index (RSI)
  • MAIA 45.57
  • AMPG 53.83
  • Support Level
  • MAIA $1.50
  • AMPG $2.78
  • Resistance Level
  • MAIA $1.73
  • AMPG $3.72
  • Average True Range (ATR)
  • MAIA 0.09
  • AMPG 0.30
  • MACD
  • MAIA 0.01
  • AMPG 0.01
  • Stochastic Oscillator
  • MAIA 42.86
  • AMPG 47.01

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

Share on Social Networks: